• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1000多例患者的甲状旁腺癌:一项基于人群水平的分析。

Parathyroid carcinoma in more than 1,000 patients: A population-level analysis.

作者信息

Sadler Claire, Gow Kenneth W, Beierle Elizabeth A, Doski John J, Langer Monica, Nuchtern Jed G, Vasudevan Sanjeev A, Goldfarb Melanie

机构信息

Department of Surgery, University of Southern California Keck School of Medicine, Los Angeles, CA.

Division of General and Thoracic Surgery, Seattle Children's Hospital, Seattle, WA.

出版信息

Surgery. 2014 Dec;156(6):1622-9; discussion 1629-30. doi: 10.1016/j.surg.2014.08.069. Epub 2014 Nov 11.

DOI:10.1016/j.surg.2014.08.069
PMID:25456964
Abstract

BACKGROUND

Parathyroid carcinoma (PC) is a rare malignancy with a moderate prognosis. The staging system, prognostic indicators, and optimal surgical management are still under debate. This large cohort explores prognostic factors for PC.

METHODS

1,022 cases of PC in the 1998-2011 National Cancer Data Base that underwent surgery were examined for predictors of lower overall survival (OS) and relative risk (RR) of death at 5 years.

RESULTS

The 5-year OS was 81.1% in 528 patients with ≥ 60 months of follow-up. The overall cohort was mainly non-Hispanic (96.5%), white (77.4%), and insured (94.3%), with a median age of 57 years. Mean OS was lower and RR of death greater in older (P < .001), black (P = .007) patients with a secondary malignancy (P = .015) and ≥ 2 comorbidities (P = .005), whose surgical specimen had positive surgical margins (P = .026) or positive lymph nodes (P < .001). Multivariate cox regression demonstrated that positive lymph nodes (hazard ratio [HR], 6.47; 95% CI, 1.81-23.11) and older age (HR, 2.35; 95% CI, 1.25-4.43) were associated with lower OS.

CONCLUSION

PC is a rare malignancy with a 5-year OS of 81.1%. Positive lymph nodes and older age predict lower OS and an increased risk of death.

摘要

背景

甲状旁腺癌(PC)是一种预后中等的罕见恶性肿瘤。其分期系统、预后指标及最佳手术治疗方案仍存在争议。本大型队列研究探讨了甲状旁腺癌的预后因素。

方法

对1998 - 2011年国家癌症数据库中1022例行手术治疗的甲状旁腺癌病例进行分析,以确定总体生存率(OS)较低及5年死亡相对风险(RR)的预测因素。

结果

528例随访时间≥60个月的患者5年总生存率为81.1%。整个队列主要为非西班牙裔(96.5%)、白人(77.4%)且有保险(94.3%),中位年龄为57岁。年龄较大(P <.001)、黑人(P =.007)、患有继发性恶性肿瘤(P =.015)及≥2种合并症(P =.005)、手术标本切缘阳性(P =.026)或淋巴结阳性(P <.001)的患者,其平均总生存率较低,死亡相对风险较高。多因素Cox回归分析显示,淋巴结阳性(风险比[HR],6.47;95%可信区间[CI],1.81 - 23.11)和年龄较大(HR,2.35;95% CI,1.25 - 4.43)与较低的总生存率相关。

结论

甲状旁腺癌是一种罕见的恶性肿瘤,5年总生存率为81.1%。淋巴结阳性和年龄较大预示着较低的总生存率和死亡风险增加。

相似文献

1
Parathyroid carcinoma in more than 1,000 patients: A population-level analysis.1000多例患者的甲状旁腺癌:一项基于人群水平的分析。
Surgery. 2014 Dec;156(6):1622-9; discussion 1629-30. doi: 10.1016/j.surg.2014.08.069. Epub 2014 Nov 11.
2
Is central lymph node dissection necessary for parathyroid carcinoma?甲状旁腺癌是否需要进行中央淋巴结清扫?
Surgery. 2014 Dec;156(6):1336-41; discussion 1341. doi: 10.1016/j.surg.2014.08.005. Epub 2014 Nov 11.
3
Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy.通过对接受手术和术后放疗的头颈部鳞状细胞癌患者进行递归划分分析来定义风险组。
Cancer. 2005 Oct 1;104(7):1408-17. doi: 10.1002/cncr.21340.
4
Parathyroid carcinoma.
Ear Nose Throat J. 2008 Sep;87(9):502-4.
5
Parathyroid Carcinoma: An Update on Treatment Outcomes and Prognostic Factors from the National Cancer Data Base (NCDB).甲状旁腺癌:来自国家癌症数据库(NCDB)的治疗结果与预后因素最新情况
Ann Surg Oncol. 2015 Nov;22(12):3990-5. doi: 10.1245/s10434-015-4672-3. Epub 2015 Jun 16.
6
Trends in the incidence and treatment of parathyroid cancer in the United States.美国甲状旁腺癌的发病率及治疗趋势。
Cancer. 2007 May 1;109(9):1736-41. doi: 10.1002/cncr.22599.
7
Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.膀胱癌根治性膀胱切除术后软组织切缘阳性与癌症特异性生存
J Urol. 2007 Dec;178(6):2308-12; discussion 2313. doi: 10.1016/j.juro.2007.08.023. Epub 2007 Oct 22.
8
Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.在根治性膀胱切除术中,淋巴结阴性的患者中,淋巴管浸润与总生存期、特定病因生存期以及局部和远处复发独立相关。
J Clin Oncol. 2005 Sep 20;23(27):6533-9. doi: 10.1200/JCO.2005.05.516. Epub 2005 Aug 22.
9
Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study.决定皮肤鳞状细胞癌预后的危险因素分析:一项前瞻性研究。
Lancet Oncol. 2008 Aug;9(8):713-20. doi: 10.1016/S1470-2045(08)70178-5. Epub 2008 Jul 9.
10
Prognostic factors and staging systems in parathyroid cancer: a multicenter cohort study.甲状旁腺癌的预后因素和分期系统:一项多中心队列研究。
Surgery. 2014 Nov;156(5):1132-44. doi: 10.1016/j.surg.2014.05.014. Epub 2014 Oct 17.

引用本文的文献

1
Diagnostic and Surgical Challenges in Parathyroid Neoplasia: An Extensive Analysis of a Single Endocrine Surgery Center Cohort of Patients.甲状旁腺肿瘤的诊断与手术挑战:对单一内分泌外科中心患者队列的深入分析
Cancers (Basel). 2025 May 26;17(11):1783. doi: 10.3390/cancers17111783.
2
The impact of management traps on surgical strategies in parathyroid benign and malignant tumors-related PHPT: a retrospective cohort study.管理陷阱对甲状旁腺良性和恶性肿瘤相关原发性甲状旁腺功能亢进手术策略的影响:一项回顾性队列研究。
Front Oncol. 2025 May 15;15:1535089. doi: 10.3389/fonc.2025.1535089. eCollection 2025.
3
Diagnostic and Therapeutic Challenges in Parathyroid Cancers: 15 Years' Experience in a Tertiary Center and an Endocrine Surgery Referral Hospital.
甲状旁腺癌的诊断与治疗挑战:三级中心及内分泌外科转诊医院的15年经验
J Clin Med. 2025 Mar 13;14(6):1932. doi: 10.3390/jcm14061932.
4
Microwave ablation permits an effective and safe treatment for lung metastasis of parathyroid carcinoma: A Retrospective Single-Center Study.微波消融术为甲状旁腺癌肺转移提供了一种有效且安全的治疗方法:一项单中心回顾性研究。
Endocrine. 2025 Feb 23. doi: 10.1007/s12020-025-04201-2.
5
Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.头颈部、泌尿生殖系统及妇科系统神经内分泌肿瘤、原发灶不明肿瘤、甲状旁腺癌及甲状腺内胸腺肿瘤:ESMO临床实践指南之诊断、治疗及随访
ESMO Open. 2024 Oct;9(10):103664. doi: 10.1016/j.esmoop.2024.103664. Epub 2024 Oct 1.
6
Pembrolizumab with external radiation therapy effectively controlled TMB-high unresectable recurrent parathyroid cancer: a case report with review of literature.帕博利珠单抗联合外放射治疗有效控制 TMB 高不可切除复发性甲状旁腺癌:病例报告并文献复习。
Endocr J. 2024 Nov 1;71(11):1069-1075. doi: 10.1507/endocrj.EJ24-0126. Epub 2024 Jul 10.
7
The prognostic value of lymph node dissection in patients with parathyroid carcinoma.甲状旁腺癌患者淋巴结清扫的预后价值。
Gland Surg. 2024 Apr 29;13(4):500-511. doi: 10.21037/gs-23-501. Epub 2024 Apr 9.
8
Cervicomediastinal Hematoma: Atypical Presentation of a Parathyroid Carcinoma.颈纵隔血肿:甲状旁腺癌的非典型表现
JCEM Case Rep. 2024 Apr 18;2(4):luae063. doi: 10.1210/jcemcr/luae063. eCollection 2024 Apr.
9
Comparison of prognosis after partial and total surgical resection for parathyroid carcinoma: an inverse probability of treatment weighting analysis of the SEER database.甲状旁腺癌行部分切除术与根治性切除术预后的比较:基于 SEER 数据库的逆概率治疗加权分析。
Front Endocrinol (Lausanne). 2023 Oct 16;14:1167508. doi: 10.3389/fendo.2023.1167508. eCollection 2023.
10
Parathyroid Retrospective Analysis of Neoplasms Incidence (pTRANI Study): An Italian Multicenter Study on Parathyroid Carcinoma and Atypical Parathyroid Tumour.甲状旁腺肿瘤发病率回顾性分析(pTRANI研究):一项关于甲状旁腺癌和非典型甲状旁腺肿瘤的意大利多中心研究。
J Clin Med. 2023 Sep 29;12(19):6297. doi: 10.3390/jcm12196297.